Intravenous golimumab in a dosage of 2 mg/kg, initially given every 4 weeks but then every 8 weeks, in addition to methotrexate, is effective in the treatment of patients with rheumatoid arthritis. This weight-based infusion is administered over thirty minutes with an acceptable safety profile. Since it is a relatively new formulation, more time will be required to assess its specific role in the rheumatologists’ armamentarium and to appreciate more fully its long-term safety.


    Zugriff

    Zugriff prüfen

    Verfügbarkeit in meiner Bibliothek prüfen

    Bestellung bei Subito €


    Exportieren, teilen und zitieren



    Titel :

    Intravenous golimumab in rheumatoid arthritis


    Beteiligte:

    Erschienen in:

    Erscheinungsdatum :

    2014-07-01


    Format / Umfang :

    8 pages




    Medientyp :

    Aufsatz (Zeitschrift)


    Format :

    Elektronische Ressource


    Sprache :

    Englisch




    New Therapeutic Approaches for Rheumatoid Arthritis

    Chen, Q. / Wei, W. | British Library Online Contents | 2005


    Muehrcke Lines Associated to Active Rheumatoid Arthritis

    Chavez-Lopez, M.A. / Arce-Martinez, F.J. / Tello-Esparza, A. | British Library Online Contents | 2013


    A Case of Methimazole-Induced Chronic Arthritis Masquerading as Seronegative Rheumatoid Arthritis

    Gruber, C.N. / Finzel, K. / Gruber, B.L. | British Library Online Contents | 2014


    Anxiety, depression and hostility in patients with psoriasic arthritis and rheumatoid arthritis

    Michelidakis, K. / Myriokefalitakis, J. / Akkizidou, A. et al. | British Library Conference Proceedings | 1998


    Tuberculous Peritonitis in a Patient With Rheumatoid Arthritis

    Kagohashi, K. / Ohara, G. / Kurishima, K. et al. | British Library Online Contents | 2014